RUNX2 and breast cancer: RUNX2 expression can also drive tumorsphere formation, a marker of stemness and, in partnership with TAZ, can result in increased shedding of soluble E-cadherin, which in turn can cooperate with HER2 in driving breast cancer cell growth [137].